Patents by Inventor Jean-Luc Blond

Jean-Luc Blond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120190569
    Abstract: A genomic retroviral nucleic material, in an isolated or purified state, at least partially functional or non-functional, wherein the genome comprises a reference nucleotide sequence selected from the group including sequences of SEQ ID NOs: 1-15, their complementary sequences, and their equivalent sequences, in particular, nucleotide sequences having, for every series of 100 contiguous monomers, at least 70% and preferably at least 90% homology with the sequences of SEQ ID NOs: 1-15.
    Type: Application
    Filed: December 23, 2011
    Publication date: July 26, 2012
    Applicant: BIOMERIEUX
    Inventors: Frédéric BESEME, Jean-Luc BLOND, Olivier BOUTON, Bernard MANDRAND, Francois MALLET, Hervé PERRON
  • Publication number: 20100267014
    Abstract: The present invention concerns an in vitro method for determining, from a biological sample, the response to a patient suffering from rheumatoid arthritis to a treatment directed against a cytokine involved in the inflammatory process of the disease, characterized in that it consists in measuring the expression of the gene encoding synoviolin.
    Type: Application
    Filed: February 28, 2006
    Publication date: October 21, 2010
    Applicant: HOSPICES CIVILS DE LYON
    Inventors: Myew-Ling Toh, Pierre Miossec, Jean-Luc Blond, Bruno Mougin
  • Patent number: 7442550
    Abstract: A method for detecting the expression of a polypeptide in cells and for detecting the interaction between a polypeptide and cells, ex vivo or in vitro, wherein the polypeptide is selected from the group consisting of: a peptide comprising the cyt domain of the envelope protein of the human endogenous retrovirus, HERV-W; a peptide comprising amino acids 448-538 of SEQ ID NO: 1; and a peptide comprising a sequence having, for any series of 20 amino acids, at least 80% identity with amino acids 448-538 of SEQ ID NO: 1. Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: October 28, 2008
    Assignees: Biomerieux, Institut National de la Sante et de la Recherche Medicale
    Inventors: Francois Mallet, Francois-Loic Cosset, Jean-Luc Blond, Dimitri Lavillette, Olivier Bouton, Alessia Ruggieri
  • Publication number: 20040176314
    Abstract: The invention concerns a genomic retroviral nucleic material, in an isolated or purified state, at least partially functional or non-functional, wherein the genome comprises a reference nucleotide sequence selected from the group including sequences of SEQ ID NOs: 1-15, their complementary sequences, and their equivalent sequences, in particular, nucleotide sequences having, for every series of 100 contiguous monomers, at least 70% and preferably at least 90% homology with the sequences of SEQ ID NOs: 1-15. The invention also concerns the application of this material.
    Type: Application
    Filed: November 21, 2003
    Publication date: September 9, 2004
    Applicant: BIO MERIEUX
    Inventors: Frederic Beseme, Jean-Luc Blond, Olivier Bouton, Bernard Mandrand, Francois Mallet, Herve Perron